YZE-98066-96496
5 vaccinations
14 coded responses
59 check-ins
14 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 967 / HI
- Registered
- 2021-03-15
- Relationship
- Self
- Race
- Native Hawaiian or other Pacific Islander
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-15
Registered in v-safe
-
2021-03-15
Dose 1 — Pfizer-BioNTech
-
2021-03-16
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-03-16
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-17
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction, Self-medication — Feeling: Fair · Site: Pain, Swelling · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Histamine reaction that started at 7:30 am yesterday. Yesterday it was severe, necessitating BenadrylMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-20
-
2021-03-21
Survey response — days 1–6 daily, dose 1MedDRA: Urticaria — Feeling: Fair · Rash, not including the immediate area around the injection siteFree text: Mild histamine reaction with the rashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-22
Health check-in — day 7, dose 1Feeling: Fair · Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-03-29
-
2021-04-05
Dose 2 — Pfizer-BioNTech
-
2021-04-05
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-07
Survey response — days 1–6 daily, dose 2MedDRA: Axillary mass, Lymphadenitis — Feeling: Poor · Site: Pain, Itching · Fever · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Inflamed lymph node with lump in armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-08
Survey response — days 1–6 daily, dose 2MedDRA: Axillary mass, Lymphadenopathy — Feeling: Poor · Site: Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Swollen lymph node and lump in armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaFree text: Swollen lymph node. No pain today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-04-12
Health check-in — day 7, dose 2Feeling: Fair · Site: Itching · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-19
- 2021-04-26
-
2021-05-03
Survey response — day 28, dose 2MedDRA: Bladder disorder, Office visit, Pyrexia, Renal disorder — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Bladder or kidney infection symptoms. Fever. · Healthcare visit (other): Visit with primary care physician. Urine test.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-10
- 2021-05-17
- 2021-07-05
- 2021-10-04
-
2021-10-18
Dose 3 — Pfizer-BioNTech
- 2021-10-18
-
2021-10-19
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Poor · Site: Itching · Fever · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolFree text: Pain in left armpitMedDRA releases: 2024-11 · check-in free text available
-
2021-10-20
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Poor · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Pain in armpitMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: Pain in armpitMedDRA releases: 2024-11 · check-in free text available
-
2021-10-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness, DiarrheaAdult check-in
-
2021-10-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2021-11-24
- 2021-11-29
- 2022-01-17
- 2022-03-15
-
2022-03-18
Call successfulParticipant prefers to complete VAERS report online
-
2022-04-18
Dose 4 — Pfizer-BioNTech
- 2022-04-18
- 2022-04-18
-
2022-04-19
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2022-04-20
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Rash, not including the immediate area around the injection siteFree text: Lymph node swelling in armpit in injection armMedDRA releases: 2024-11 · check-in free text available
-
2022-04-21
Survey response — days 1–6 daily, dose 4MedDRA: Immune system disorder, Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolFree text: Lymph node swelling, histamine reactionMedDRA releases: 2024-11 · check-in free text available
-
2022-04-22
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction, Lymphadenopathy — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Histamine reaction, swollen lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction, Lymphadenopathy — Feeling: Poor · Site: Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Histamine reaction, swollen lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-04-25
Health check-in — day 7, dose 4Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2022-05-02
- 2022-05-09
- 2022-05-16
-
2022-05-23
Survey response — day 35, dose 4MedDRA: Fatigue, Headache, Oropharyngeal pain, Pyrexia, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Sore throat, fever, congestion, headache, fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-05-23
Report sent to call center — day 35, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-05-24
-
2022-05-25
Callback requested for11:00AM ET
- 2022-05-30
- 2022-07-18
-
2022-10-02
Dose 5 — Moderna
- 2022-10-17
- 2022-10-17
- 2022-10-23
- 2022-10-30
- 2022-11-08
- 2022-11-13
- 2023-01-01
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-15 | Pfizer-BioNTech | |
| 2 | 2021-04-05 | Pfizer-BioNTech | |
| 3 | 2021-10-18 | Pfizer-BioNTech | No |
| 4 | 2022-04-18 | Pfizer-BioNTech | No |
| 5 | 2022-10-02 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-16 | Successful | Participant prefers to complete VAERS report online |
| 2021-04-07 | Successful | Participant prefers to complete VAERS report online |
| 2021-05-03 | Successful 2022-03-18 |
Participant prefers to complete VAERS report online |
| 2022-05-23 | Unsuccessful |
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Histamine reaction that started at 7:30 am yesterday. Yesterday it was severe, necessitating Benadryl
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Mild histamine reaction with the rash
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Inflamed lymph node with lump in armpit
Systemic reaction (other): Swollen lymph node and lump in armpit
Systemic reaction (other): Swollen lymph node. No pain today.
Release 8 — day 28, dose 2
Symptoms: Bladder or kidney infection symptoms. Fever.
Healthcare visit (other): Visit with primary care physician. Urine test.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Pain in left armpit
Systemic reaction (other): Pain in armpit
Systemic reaction (other): Pain in armpit
Release 11 — days 1–6 daily, dose 4
Systemic reaction (other): Lymph node swelling in armpit in injection arm
Systemic reaction (other): Lymph node swelling, histamine reaction
Systemic reaction (other): Histamine reaction, swollen lymph node
Systemic reaction (other): Histamine reaction, swollen lymph node
Release 11 — day 35, dose 4
Symptoms: Sore throat, fever, congestion, headache, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Bladder disorder | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SD | Renal disorder | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Axillary mass | ✓ | ✓ | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Immune system disorder | · | · | ✓ |
| SRO | Lymphadenitis | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release